Vaginal vs. robotic hysterectomy for patients with endometrial cancer

A comparison of outcomes and cost of care

CC C. Nitschmann, F. Multinu, Jamie N Bakkum-Gamez, CL L. Langstraat, JA A. Occhino, AL L. Weaver, William Arthur Cliby, A. Mariani, Sean Christopher Dowdy

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: To compare outcomes and cost for patients with endometrial cancer undergoing vaginal hysterectomy (VH) or robotic hysterectomy (RH), with or without lymphadenectomy (LND). Methods: Patients undergoing planned VH (and laparoscopic LND) or RH (and robotic LND) between January 2007 and November 2012 were reviewed. Patients with stage IV disease, synchronous cancer, synchronous surgery, or treated with palliative intent were excluded. Patients were objectively triaged to LND per institutional protocol based on frozen section. Outcomes were compared between VH and RH groups matched 1:1 on propensity scores. Results: VH was planned in 153 patients; 60 (39%) had concurrent LND while 93 (61%) were low risk and did not require LND. RH was planned in 398 patients; 225 (56%) required concurrent LND and 173 (44%) did not. Among 50 PS-matched pairs without LND, there was no significant difference in complications, length of stay, readmission, or progression free survival. However, median operative time was 1.3. h longer and median 30-day cost $3150 higher for RH compared to VH (both p. <. 0.001).Among patients requiring LND, 42 PS-matched pairs were identified. Median operative time was not different when pelvic and para-aortic LND was performed, and 12. min longer in the VH group for pelvic LND alone (p = 0.03). Median 30-day cost was $921 higher for RH compared to VH when LND was required (p = 0.08). Conclusion: Utilization of vaginal hysterectomy for endometrial cancer results in similar surgical and oncologic outcomes and lower costs compared to RH and should be considered for appropriate patients with a low risk of requiring LND.

Original languageEnglish (US)
JournalGynecologic Oncology
DOIs
StateAccepted/In press - Jan 16 2017

Fingerprint

Vaginal Hysterectomy
Robotics
Endometrial Neoplasms
Hysterectomy
Costs and Cost Analysis
Operative Time
Propensity Score
Frozen Sections
Lymph Node Excision
Disease-Free Survival
Length of Stay
Research Design

Keywords

  • Cost of care
  • Endometrial cancer
  • Minimally invasive surgery
  • Robotic hysterectomy
  • Vaginal hysterectomy

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Vaginal vs. robotic hysterectomy for patients with endometrial cancer : A comparison of outcomes and cost of care. / Nitschmann, CC C.; Multinu, F.; Bakkum-Gamez, Jamie N; Langstraat, CL L.; Occhino, JA A.; Weaver, AL L.; Cliby, William Arthur; Mariani, A.; Dowdy, Sean Christopher.

In: Gynecologic Oncology, 16.01.2017.

Research output: Contribution to journalArticle

@article{b532874e86af4b84b5c5a0eca9620aaf,
title = "Vaginal vs. robotic hysterectomy for patients with endometrial cancer: A comparison of outcomes and cost of care",
abstract = "Objective: To compare outcomes and cost for patients with endometrial cancer undergoing vaginal hysterectomy (VH) or robotic hysterectomy (RH), with or without lymphadenectomy (LND). Methods: Patients undergoing planned VH (and laparoscopic LND) or RH (and robotic LND) between January 2007 and November 2012 were reviewed. Patients with stage IV disease, synchronous cancer, synchronous surgery, or treated with palliative intent were excluded. Patients were objectively triaged to LND per institutional protocol based on frozen section. Outcomes were compared between VH and RH groups matched 1:1 on propensity scores. Results: VH was planned in 153 patients; 60 (39{\%}) had concurrent LND while 93 (61{\%}) were low risk and did not require LND. RH was planned in 398 patients; 225 (56{\%}) required concurrent LND and 173 (44{\%}) did not. Among 50 PS-matched pairs without LND, there was no significant difference in complications, length of stay, readmission, or progression free survival. However, median operative time was 1.3. h longer and median 30-day cost $3150 higher for RH compared to VH (both p. <. 0.001).Among patients requiring LND, 42 PS-matched pairs were identified. Median operative time was not different when pelvic and para-aortic LND was performed, and 12. min longer in the VH group for pelvic LND alone (p = 0.03). Median 30-day cost was $921 higher for RH compared to VH when LND was required (p = 0.08). Conclusion: Utilization of vaginal hysterectomy for endometrial cancer results in similar surgical and oncologic outcomes and lower costs compared to RH and should be considered for appropriate patients with a low risk of requiring LND.",
keywords = "Cost of care, Endometrial cancer, Minimally invasive surgery, Robotic hysterectomy, Vaginal hysterectomy",
author = "Nitschmann, {CC C.} and F. Multinu and Bakkum-Gamez, {Jamie N} and Langstraat, {CL L.} and Occhino, {JA A.} and Weaver, {AL L.} and Cliby, {William Arthur} and A. Mariani and Dowdy, {Sean Christopher}",
year = "2017",
month = "1",
day = "16",
doi = "10.1016/j.ygyno.2017.03.002",
language = "English (US)",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Vaginal vs. robotic hysterectomy for patients with endometrial cancer

T2 - A comparison of outcomes and cost of care

AU - Nitschmann, CC C.

AU - Multinu, F.

AU - Bakkum-Gamez, Jamie N

AU - Langstraat, CL L.

AU - Occhino, JA A.

AU - Weaver, AL L.

AU - Cliby, William Arthur

AU - Mariani, A.

AU - Dowdy, Sean Christopher

PY - 2017/1/16

Y1 - 2017/1/16

N2 - Objective: To compare outcomes and cost for patients with endometrial cancer undergoing vaginal hysterectomy (VH) or robotic hysterectomy (RH), with or without lymphadenectomy (LND). Methods: Patients undergoing planned VH (and laparoscopic LND) or RH (and robotic LND) between January 2007 and November 2012 were reviewed. Patients with stage IV disease, synchronous cancer, synchronous surgery, or treated with palliative intent were excluded. Patients were objectively triaged to LND per institutional protocol based on frozen section. Outcomes were compared between VH and RH groups matched 1:1 on propensity scores. Results: VH was planned in 153 patients; 60 (39%) had concurrent LND while 93 (61%) were low risk and did not require LND. RH was planned in 398 patients; 225 (56%) required concurrent LND and 173 (44%) did not. Among 50 PS-matched pairs without LND, there was no significant difference in complications, length of stay, readmission, or progression free survival. However, median operative time was 1.3. h longer and median 30-day cost $3150 higher for RH compared to VH (both p. <. 0.001).Among patients requiring LND, 42 PS-matched pairs were identified. Median operative time was not different when pelvic and para-aortic LND was performed, and 12. min longer in the VH group for pelvic LND alone (p = 0.03). Median 30-day cost was $921 higher for RH compared to VH when LND was required (p = 0.08). Conclusion: Utilization of vaginal hysterectomy for endometrial cancer results in similar surgical and oncologic outcomes and lower costs compared to RH and should be considered for appropriate patients with a low risk of requiring LND.

AB - Objective: To compare outcomes and cost for patients with endometrial cancer undergoing vaginal hysterectomy (VH) or robotic hysterectomy (RH), with or without lymphadenectomy (LND). Methods: Patients undergoing planned VH (and laparoscopic LND) or RH (and robotic LND) between January 2007 and November 2012 were reviewed. Patients with stage IV disease, synchronous cancer, synchronous surgery, or treated with palliative intent were excluded. Patients were objectively triaged to LND per institutional protocol based on frozen section. Outcomes were compared between VH and RH groups matched 1:1 on propensity scores. Results: VH was planned in 153 patients; 60 (39%) had concurrent LND while 93 (61%) were low risk and did not require LND. RH was planned in 398 patients; 225 (56%) required concurrent LND and 173 (44%) did not. Among 50 PS-matched pairs without LND, there was no significant difference in complications, length of stay, readmission, or progression free survival. However, median operative time was 1.3. h longer and median 30-day cost $3150 higher for RH compared to VH (both p. <. 0.001).Among patients requiring LND, 42 PS-matched pairs were identified. Median operative time was not different when pelvic and para-aortic LND was performed, and 12. min longer in the VH group for pelvic LND alone (p = 0.03). Median 30-day cost was $921 higher for RH compared to VH when LND was required (p = 0.08). Conclusion: Utilization of vaginal hysterectomy for endometrial cancer results in similar surgical and oncologic outcomes and lower costs compared to RH and should be considered for appropriate patients with a low risk of requiring LND.

KW - Cost of care

KW - Endometrial cancer

KW - Minimally invasive surgery

KW - Robotic hysterectomy

KW - Vaginal hysterectomy

UR - http://www.scopus.com/inward/record.url?scp=85017126336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017126336&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2017.03.002

DO - 10.1016/j.ygyno.2017.03.002

M3 - Article

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

ER -